Problems of drug therapy of epilepsy in developing countries.
Unavailability of drug therapy to patients with epilepsy in developing countries is probably the most important obstacle to effective primary care of epilepsy in these countries. At the recent international Merritt-Putnam Symposium in New Delhi, poor availability of drug supply and poor access to drug therapy were identified as major constraints to availability of drug therapy. The extent and magnitude of the problems are examined in this communication and methods of improving drug therapy of epilepsy in developing countries are suggested.
Adamolekun
B
B
Instituut voor Epilepsiebestrijding Heemstede, The Netherlands.
Meinardi
H
H
D000927:Anticonvulsants / Q000627:therapeutic use*; D003153:Community Health Services; D003906:Developing Countries; D004827:Epilepsy / Q000188:drug therapy*; D006297:Health Services Accessibility / Q000191:economics; D006801:Humans; D010634:Phenobarbital / Q000009:adverse effects / Q000627:therapeutic use; D012423:Rural Health
D000927:Anticonvulsants; D010634:Phenobarbital